Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy - PubMed

Review

Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy

Fatma Ferda Verit et al. Asian Pac J Cancer Prev. 2013.

Free article

Abstract

The aim of this review article was to evaluate the relationship and the possible etiological mechanisms between endometriosis, leiomyoma (LM) and adenomyosis and gynecological cancers, such as ovarian and endometrial cancer and leiomyosarcoma (LMS). MEDLINE was searched for all articles written in the English literature from July 1966 to May 2013. Reports were collected systematically and all the references were also reviewed. Malignant transformation of gynecologic benign diseases such as endometriosis, adenomyosis and LM to ovarian and endometrial cancer remains unclear. Hormonal factors, inflammation, familial predisposition, genetic alterations, growth factors, diet, altered immune system, environmental factors and oxidative stress may be causative factors in carcinogenesis. Early menarche, low parity, late menopause and infertility have also been implicated in the pathogenesis of these cancers. Ovarian cancers and endometriosis have been shown to have common genetic alterations such as loss of heterozygosity (LOH), PTEN, p53, ARID1A mutations. MicroRNAs have also been implicated in malignant transformation. Inflammation releases proinflammatory cytokines, and activates tumor associated macrophages (TAMS) and nuclear factor kappa b (NF-KB) signaling pathways that promote genetic mutations and carcinogenesis. MED12 mutations in LM and smooth muscle tumors of undetermined malignant potential (STUMP) may contribute to malignant transformation to LMS. A hyperestrogenic state may be shared in common with pathogenesis of adenomyosis, LM and endometrial cancer. However, the effect of these benign gynecologic diseases on endometrial cancer should be studied in detail. This review study indicates that endometriosis, LM, adenomyosis may be associated with increased risk of gynecological cancers such as endometrial and ovarian cancers. The patients who have these gynecological benign diseases should be counseled about the future risks of developing cancer. Further studies are needed to investigate the relationship between STUMPs, LMS and LM and characteristics and outcome endometrial carcinoma in adenomyotic patients.

Similar articles

• Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.

  Szubert M, Kozirog E, Wilczynski J. Szubert M, et al. Int J Environ Res Public Health. 2022 Feb 17;19(4):2294. doi: 10.3390/ijerph19042294. Int J Environ Res Public Health. 2022. PMID: 35206475 Free PMC article. Review.

• Report of the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development-sponsored workshop: gynecology and women's health-benign conditions and cancer.

  Samimi G, Sathyamoorthy N, Tingen CM, Mazloomdoost D, Conroy J, Heckman-Stoddard B, Halvorson LM. Samimi G, et al. Am J Obstet Gynecol. 2020 Dec;223(6):796-808. doi: 10.1016/j.ajog.2020.08.049. Epub 2020 Aug 21. Am J Obstet Gynecol. 2020. PMID: 32835714

• There is no significant correlation of adenomyosis with benign, premalignant and malignant gynecological pathologies. Retrospective study on 647 specimens.

  Matalliotakis M, Zervou MI, Matalliotaki C, Goulielmos GN, Krithinakis K, Kapetanios G, Kalogiannidis I. Matalliotakis M, et al. Ginekol Pol. 2022;93(6):467-472. doi: 10.5603/GP.a2021.0174. Epub 2022 Jan 24. Ginekol Pol. 2022. PMID: 35072225

• The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.

  Kok VC, Tsai HJ, Su CF, Lee CK. Kok VC, et al. Int J Gynecol Cancer. 2015 Jul;25(6):968-76. doi: 10.1097/IGC.0000000000000454. Int J Gynecol Cancer. 2015. PMID: 25893280

• Malignant transformation of adenomyosis: literature review and meta-analysis.

  Yuan H, Zhang S. Yuan H, et al. Arch Gynecol Obstet. 2019 Jan;299(1):47-53. doi: 10.1007/s00404-018-4991-2. Epub 2018 Dec 5. Arch Gynecol Obstet. 2019. PMID: 30519753 Review.

Cited by

• The correlation between women's various gynaecological diseases to ovarian cancer in Sulaimaniyah City, Iraq.

  Karim SMH, Fattah CN. Karim SMH, et al. J Int Med Res. 2023 Apr;51(4):3000605231158949. doi: 10.1177/03000605231158949. J Int Med Res. 2023. PMID: 37013263 Free PMC article.

• Retrospective evaluation of pathological results among women with ovarian endometriomas versus teratomas.

  Matalliotakis M, Matalliotaki C, Zervou MI, Krithinakis K, Goulielmos GN, Kalogiannidis I, Arici A, Spandidos DA, Matalliotakis I. Matalliotakis M, et al. Mol Clin Oncol. 2019 Jun;10(6):592-596. doi: 10.3892/mco.2019.1844. Epub 2019 Apr 15. Mol Clin Oncol. 2019. PMID: 31086669 Free PMC article.

• A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy.

  Sasamori Y, Takehara K, Terashima T, Onodera T, Yatsuki K, Nakagawa I, Takahashi Y, Nishida H, Ichinose T, Hiraike H, Nagasaka K. Sasamori Y, et al. BMC Womens Health. 2021 Aug 19;21(1):306. doi: 10.1186/s12905-021-01442-x. BMC Womens Health. 2021. PMID: 34412607 Free PMC article.

• Adenomyosis: Back to the future?

  Ferraz Z, Nogueira-Martins N, Nogueira-Martins F. Ferraz Z, et al. Facts Views Vis Obgyn. 2017 Mar;9(1):15-20. Facts Views Vis Obgyn. 2017. PMID: 28721180 Free PMC article.

• Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.

  Szubert M, Kozirog E, Wilczynski J. Szubert M, et al. Int J Environ Res Public Health. 2022 Feb 17;19(4):2294. doi: 10.3390/ijerph19042294. Int J Environ Res Public Health. 2022. PMID: 35206475 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Asian Pacific Organization for Cancer Prevention

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal